Stay updated on Entinostat + Pembrolizumab in Lymphomas Clinical Trial
Sign up to get notified when there's something new on the Entinostat + Pembrolizumab in Lymphomas Clinical Trial page.

Latest updates to the Entinostat + Pembrolizumab in Lymphomas Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedThis update is a minor site revision (Revision: v3.4.2) with removal of an older funding-status notice, and does not modify core trial details or navigation. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check21 days agoChange DetectedA government funding status notice banner was added and the page revision updated from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check28 days agoChange DetectedAdded a 'Show glossary' option and a new revision note (Revision: v3.4.0). Minor formatting changes include capitalization tweaks to 'Last Update Submitted that Met QC Criteria' vs 'Last Update Submitted that met QC Criteria' and 'No FEAR Act Data' vs 'No FEAR Act data'. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check42 days agoChange DetectedRevision label updated from v3.3.3 to v3.3.4 in the page footer. No substantive study information appears to have changed.SummaryDifference0.1%

- Check63 days agoChange DetectedAdded a dedicated 'Locations' section listing study sites in Illinois, New Jersey, and New York. Removed the separate 'Illinois Locations', 'New Jersey Locations', and 'New York Locations' subsections.SummaryDifference0.4%

- Check92 days agoChange DetectedRevision label updated from v3.2.0 to v3.3.2 on the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Entinostat + Pembrolizumab in Lymphomas Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Entinostat + Pembrolizumab in Lymphomas Clinical Trial page.